Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F5QXX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,648
Award facts
- Contract value 100% obligated
- $30,647.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,647.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of January 8, 2026. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The award represents a task order under the company's parent entity Cencora, Inc.'s larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031.
This delivery order supports the Defense Logistics Agency's medical supply chain operations by procuring REPATHA, a specialty cardiovascular medication used to treat high cholesterol, in the convenient auto-injector formulation. The transaction exemplifies AmerisourceBergen's extensive portfolio of pharmaceutical deliveries to federal agencies, which encompasses brand-name medications, generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains. As a critical vendor in the federal medical supply chain, the company maintains demonstrated capability to efficiently fulfill government requirements for essential pharmaceutical commodities required by military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F5QXX?
SPE2DR26F5QXX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F5QXX worth?
The government has obligated $30,648 on SPE2DR26F5QXX.
Is contract SPE2DR26F5QXX an order under another contract?
Yes. SPE2DR26F5QXX is a delivery order under SPE2DR25D2013, an indefinite delivery contract.
Was contract SPE2DR26F5QXX competed?
The extent of competition for SPE2DR26F5QXX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award